MeSH tree: N05.715.360.575.575.800
Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate noninferiority to paclitaxel/carboplatin followed by letrozole (PC/L) for progression-free survival (PFS) ...
Apr 13, 2026
0
2
Nearly 40% of public-sector physiotherapists want to leave their current job, posing a substantial threat to workforce stability and quality of patient care, University of Otago—Ōtākou Whakaihu Waka research has found. The ...
Apr 9, 2026
0
3
Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to surgery. ...
Mar 26, 2026
0
9
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet. Marginal zone lymphoma ...
Mar 4, 2026
0
6
When a trauma patient enters the emergency department, their potential for survival often depends on what happens within the first minutes after their arrival. After studying trauma resuscitation teams at UPMC Presbyterian ...
Mar 4, 2026
0
6
Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact on survival among people living with multiple myeloma, according to new international ...
Mar 2, 2026
0
9
Perioperative enfortumab vedotin plus pembrolizumab and surgery lead to significantly better outcomes among patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy compared with surgery ...
Feb 27, 2026
0
7
Every day in health clinics across the country, bilingual employees step into exam rooms to help patients and providers understand one another. They translate symptoms, questions, fears and instructions—often without any ...
Feb 23, 2026
0
6
A first-of-its-kind analysis has revealed significant differences in stroke outcomes and stroke care for patients on government-run traditional Medicare plans versus those on Medicare Advantage, offered by private insurers. ...
Feb 18, 2026
0
8
A study by investigators from Mass General Brigham Cancer Institute evaluates the efficacy and safety of proton therapy for patients with lower grade gliomas (LGGs). The single-arm prospective phase 2 trial results demonstrated ...
Feb 11, 2026
0
9
